United Therapeutics (UTHR) Balance Sheet

Click line-items for a historical chart and %

Current assets:
Cash and cash equivalents	953M
Marketable investments	79.6M
Accounts receivable, net of allowance of none for 2011 and 2010	224.6M
Other current assets	36.4M
Prepaid expenses
Inventories, net	92.4M
Deferred tax assets
Total current assets	1.39B
Marketable investments
Marketable investments and cash-restricted
Goodwill and other intangibles, net
Property, plant and equipment, net	488.4M
Deferred tax assets
Other assets	169.7M
Total assets	2.27B
Current liabilities:
Accounts payable
Accrued expenses
Convertible notes
Other current liabilities	60.9M
Total current liabilities	314.6M
Mortgage payable-noncurrent
Other liabilities	105M
Total liabilities	419.6M
Commitments and contingencies:	0
Common stock subject to repurchase
Stockholders' equity:
Common stock, par value $.01, 245,000,000 shares authorized, 60,817,983 and 60,017,546 shares issued, and 58,314,326 and 57,555,893 shares outstanding at June 30, 2011 and December 31, 2010, respectively	700K
Additional paid-in capital	1.84B
Accumulated other comprehensive loss	-16.8M
Treasury stock at cost, 2,503,657 and 2,461,653 shares at June 30, 2011 and December 31, 2010, respectively
Retained earnings	2.32B
Total stockholders' equity
Total liabilities and stockholders' equity	2.27B
Preferred stock {e:}
Stockholders' equity:
Preferred stock	0
Series A junior participating preferred stock
Stockholders' equity:
Preferred stock	0

Entities mentioned with UTHR